课题基金 / 基金详情

Clinical studies on the simultaneous integrated boost method using intensity modulated radiotherapy (IMRT)

Clinical studies on the simultaneous integrated boost method using intensity modulated radiotherapy (IMRT)
调强放射治疗(IMRT)同步整合增强法的临床研究
批准号:
17591300
负责人:
NISHIMURA Yasumasa
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

NISHIMURA Yasumasa的其他基金

相似基金

相关文献

中文摘要
翻译
我们完成了一项采用同步积分增强(SIB)方法的调强放射治疗(IMRT)治疗恶性胶质瘤的初步研究。我们的调强放疗方案对大体肿瘤体积(GTV)给予70Gy28次(Fr)/d 2.5Gy,边缘0.5 cm定义为计划目标体积环(PTV-G),对周围水肿区给予56Gy28fr/d 2.0Gy定义为计划目标体积环(PTV-a)。不幸的是,13例患者均出现肿瘤复发。所有患者的1年和2年总生存率分别为77%和31%。总而言之,我们的调强放疗方案并没有阻止肿瘤的进展。然而,调强放射治疗能够给两个相邻的靶点GTV和周围的水肿提供高度符合的剂量,这证明了其应用于恶性胶质瘤的合理性。74例咽癌患者调强放疗的临床结果。27例鼻咽癌患者的5年生存率为…高达75%。口咽癌和下咽癌的3年生存率分别为87%和48%。1年后仅有1/4的患者出现中度口干(2级)。对于早期口咽癌合并T1、2NOMO病,制定了SIB法治疗方案,并应用于3例患者。我们的调强适形放射治疗方案向GTV提供66Gy30fr/d 2.2Gy0.5 cm的边缘,向预防性淋巴区域提供54Gy30fr/d 1.8Gy.正电子发射断层扫描(PET)对放射治疗计划是有用的。然而,PET图像的大小随其阈值的不同而变化很大,临床上PET图像会影响目标的勾画。为了确定在PET图像中描绘目标的合适阈值,进行了静态和运动体模研究。当采用最大18FDG活度的35%作为阈值时,在轴向平面内22~37 mm的静止和运动的体模球体的PET图像基本相同。在周期运动为4s的运动模型实验中,球体的最大18FDG活性随运动距离的增加而显著下降。此外,PET图像有可能提供个性化的内部靶区体积(ITV)。较少
英文摘要
We have finished a pilot study on the treatment of malignant gliomas with intensity modulated radiotherapy (IMRT) using a simultaneous integrated boost (SIB) method. Our IMRT regimen delivered 70 Gy/28 fractions (fr)/daily 2.5 Gy to the gross tumor volume (GTV) with a 0.5-cm margin defined as the planning target volume annulus (PTV-G) and 56 Gy/28 fr/daily 2.0 Gy to the surrounding edema defined as the planning target volume annulus (PTV-a). Unfortunately, all the 13 patients experienced tumor recurrence. The 1-year and 2-year overall survival rate for all the patients was 77 and 31%, respectively. In conclusion, our IMRT regimen did not prevent tumor progression. However, the ability of IMRT to deliver highly conformative doses to two contiguous targets, GTV and the surrounding edema, justifies its application to malignant gliomas.Clinical results of 74 patients with pharyngeal cancer treated with IMRT. The 5-year survival rate for the 27 patients with nasopharyngeal cancer was as goo … More d as 75%. The 3-year survival rates for oropharyngeal and hypopharyngeal cancers were 87% and 48%, respectively. Only 1/4 of the patients treated by IMRT complained moderate xerostomia (grade 2) one year after treatment. For early oropharyngeal cancer with T1,2NOMO disease, treatment planning Of SIB method was established, and applied for three patients. Our IMRT regimen delivered 66 Gy/30 fr/daily 2.2 Gy to the GTV with a 0.5-cm margin and 54 Gy/30 fr /daily 1.8 Gy to the prophylactic lymph node areas.Positron emission tomography (PET) is useful for radiation therapy treatment planning. However, the size of PET delineation changes significantly dependent on its threshold value, and the PET image affects the target delineation clinically. To determine an appropriate threshold value for delineation of the target in PET images, static and moving phantom studies were performed. When a threshold value of 35% of the maximum 18FDG activity was adopted, PET-images were almost the same for static and moving phantom spheres of 22〜37mm in the axial plane. In moving phantom experiments with a periodic motion of 4 seconds, the maximum 18FDG activity of spheres dropped significantly dependent on moving distance. In addition, PET images have the potential to provide an individualized internal target volume (ITV). Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical results of parotid-sparing intensity moduolated radiation therapy(IMRT) for nasopharyngeal cancer(NPC).
保留腮腺调强放射治疗(IMRT)治疗鼻咽癌(NPC)的临床结果。
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Nishimura Y. Nakamatsu K, Shibata T, Kanamori S, Koike R, Hiroi K, Okubo M, Okumura M.]
通讯作者: Okumura M.
Glioblastoma multiforme:case study.In Intensity Modulated Radiation Therapy;A clinical perspective, Eds.Mundt AJ, Roeske JC (分担執筆)
多形性胶质母细胞瘤:案例研究。调强放射治疗;临床视角,Eds.Mundt AJ、Roeske JC(撰稿人)
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Suzuki M, Mori K., 西村 恭昌, 西村 恭昌, Suzuki M]
通讯作者: Suzuki M
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Nishimura Y, Shibata T, Nakamatsu K, Kanamori S, Koike R, Okubo M]
通讯作者: Okubo M
強度変調放射線療法(IMRT)の現状と展望
调强放射治疗(IMRT)的现状与展望
DOI: --
发表时间: 2006
期刊: 臨床放射線 51
影响因子: --
作者: [Zhao, et al., 西村恭昌]
通讯作者: 西村恭昌
共 27 条
    Organ-specific tolerance doses in intensity-modulated radiation therapy for head and neck cancer
    • 批准号:
      20K08009
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      NISHIMURA Yasumasa
    • 依托单位:
    Adaptive radiation therapy based on in-room CT image
    • 批准号:
      16K10406
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2016
    • 负责人:
      NISHIMURA Yasumasa
    • 依托单位:
    High precision radiation therapy based on intra-tumoral hypoxic imaging
    • 批准号:
      25461932
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      NISHIMURA Yasumasa
    • 依托单位:
    Development of the next generation radiation therapy based on molecular imaging
    • 批准号:
      22591392
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      NISHIMURA Yasumasa
    • 依托单位:
    国内基金
    海外基金
    同步X-ray成像对调控自噬的联合疗法抗三阴性乳腺癌机制研究
    基于时空信息融合的2D X-ray到3D CT图像配准实时引导肺癌放疗研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2022
    • 负责人:
      肖汉光
    • 依托单位:
    CAT、DSA、x-ray与解剖技术相结合确立小腿后外侧皮支链皮瓣血管构筑
    • 批准号:
      31860294
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      42.0万元
    • 批准年份:
      2018
    • 负责人:
      秦向征
    • 依托单位:
    基于可见光/X-ray双模式成像的稻穗产量性状无损解析
    • 批准号:
      31600287
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2016
    • 负责人:
      黄成龙
    • 依托单位: